SGI
TARO

Summit Global Investments’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Summit Global Investments’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,200
Closed -$609K – 312
2018
Q4 		$609K Buy
+7,200
New +$694K 0.09% 208

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Summit Global Investments's TARO Position: Q1 2019 in Review

Summit Global Investments sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2019, closing a stake of 7,200 shares — an estimated $609K sold.

Summit Global Investments first reported a position in TARO in Q4 2018 and held it in 1 quarter. The position peaked at $609K in Q4 2018. 104 funds tracked by Wall St. Rank hold TARO as of Q1 2019.

  • Summit Global Investments reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2019 after selling out during the quarter.
  • Summit Global Investments sold 7,200 Taro Pharmaceutical Industries Ltd. shares in Q1 2019, an estimated $609K.
  • Summit Global Investments first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2018 and held it in 1 quarter.
  • Summit Global Investments's Taro Pharmaceutical Industries Ltd. position peaked at $609K in Q4 2018.
  • 104 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2019.

Based on Summit Global Investments's 13F filing for Q1 2019, filed 14 May 2019.